CN Patent
CN117736150A — 一种高效合成奥拉帕利关键中间体的方法和其应用
Assigned to Beijing Sea Source Medical Science And Technology Co ltd · Expires 2024-03-22 · 2y expired
What this patent protects
本发明涉及药物合成领域,具体涉及一种高效合成奥拉帕利关键中间体的方法和其应用。本发明所述奥拉帕利关键中间体4的制备方法包括如下步骤: 本发明的制备方法具有操作简便,工艺稳定可控、适合于大规模工业化生产等优势。
USPTO Abstract
本发明涉及药物合成领域,具体涉及一种高效合成奥拉帕利关键中间体的方法和其应用。本发明所述奥拉帕利关键中间体4的制备方法包括如下步骤: 本发明的制备方法具有操作简便,工艺稳定可控、适合于大规模工业化生产等优势。
Drugs covered by this patent
- Lynparza (olaparib) · AstraZeneca
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.